Article Text
Statistics from Altmetric.com
THE BARE ESSENTIALS
The existence of a large number of neurological diseases in which the motor neuron is the principal site of pathology suggests that these cells and their neuronal networks have a specific set of vulnerabilities. Recent research, largely based on relatively rare genetic forms of motor neuron disease, indicates that these cells are vulnerable to defects in excitotoxicity, RNA transport and splicing, axonal protein transport, mitochondrial function, protein misfolding and oxidative stress. The most important motor neuron disease is a largely sporadic, late onset, degenerative condition, known simply as motor neuron disease (MND) or more widely as amyotrophic lateral sclerosis (ALS), which currently remains untreatable and uniformly fatal.
The core features of MND
In essence, MND is a progressive motor syndrome with clinical evidence of upper motor neuron dysfunction (spasticity, brisk reflexes, extensor plantar responses) and denervation (muscle wasting, weakness and fasciculation). It is typically asymmetrical in onset and progresses in a non-random pattern suggesting a pathological process with a focal onset and anatomically contiguous spread. Although predominantly a motor disorder, there is evidence of multisystem involvement (especially cognitive, but occasionally sensory or autonomic). The diagnosis is clinical, although imaging is usually necessary to exclude structural pathology mimicking MND. Neurophysiology should not be considered to be a diagnostic test but can provide support for the presence of denervation and exclude other conditions such as pure motor inflammatory demyelinating neuropathies.
The incidence of MND is approximately 2/100 000 population per year and there is no convincing evidence of geographical variation, although studies to date are limited to developed societies with predominantly European genetic heritage. Approximately 1/1000 death certificates list MND as the cause of death. There is no indication that MND is increasing in frequency.
The prevalence is approximately 7/100 000. General practitioners in the UK might encounter a patient with MND less than once every 10 years.
The …
Linked Articles
- Editor’s choice
Read the full text or download the PDF:
Other content recommended for you
- Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis
- Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
- Differentiating lower motor neuron syndromes
- Assessment of suspected motor neuron disease
- Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001–2012 survey results
- A rapidly progressive neuropathy
- Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis
- Molecular and cellular pathways of neurodegeneration in motor neurone disease
- Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature
- A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13